Order
Press Releases

Market Release of AlphaFlo® Canine Allograft

AlphaFlo-Press-Release-Image

Equus Innovations, a manufacturer of advanced, next-generation veterinary regenerative products, in partnership with AlphaLogix, LLC (Argyle, Texas) announced today successful market release of a new canine allograft, AlphaFlo®.

Read the Press Release
Other Posts

What Is AlphaFlo® for Dogs and How Do Veterinarians Use It?

Regenerative medicine is one of the fastest growing areas in veterinary care, and dog owners are hearing more about options like amniotic tissue allografts. AlphaFlo® is one of these products. If you have seen the name at your veterinary clinic or come across it while...

What VEGF and EGF Have to Do With AlphaFlo®

Angiogenesis, the process by which new blood vessels form from existing ones, is an important part of the tissue repair process. Adequate blood supply to tissues is essential for delivering oxygen and nutrients during the repair process, and research into factors that...

How AlphaFlo® Interacts With the Immune System

The immune system plays a central role in how the body responds to tissue injury, infection, and inflammation. Amniotic tissue has been studied for its reported immunomodulatory properties, and AlphaFlo®, as a cryopreserved canine amniotic tissue allograft, contains...